Phio Pharmaceuticals Corp.
Utility Patents
Last updated:
List of all Phio Pharmaceuticals Corp. patents 14 in total
| Status | Patent |
|---|---|
Grant | Utility: Inhibition of MAP4K4 through RNAi Filling date: 26 Sep 2025 Issue date: 22 Feb 2022 |
Grant | Utility: Reduced size self-delivering RNAI compounds Filling date: 26 Sep 2025 Issue date: 14 Sep 2021 |
Grant | Utility: Reduced size self-delivering nucleic acid compounds targeting long non-coding RNA Filling date: 26 Sep 2025 Issue date: 1 Jun 2021 |
Grant | Utility: Nucleic acid molecules targeting superoxide dismutase 1 (SOD1) Filling date: 26 Sep 2025 Issue date: 11 May 2021 |
Grant | Utility: Immunotherapy of cancer Filling date: 26 Sep 2025 Issue date: 2 Mar 2021 |
Grant | Utility: RNA interference in dermal and fibrotic indications Filling date: 26 Sep 2025 Issue date: 9 Feb 2021 |
Grant | Utility: Methods for treating aging and skin disorders using nucleic acids targeting Tyr or MMP1 Filling date: 26 Sep 2025 Issue date: 26 Jan 2021 |
Grant | Utility: Reduced size self-delivering RNAI compounds Filling date: 26 Sep 2025 Issue date: 29 Dec 2020 |
Grant | Utility: RNA interference in skin indications Filling date: 26 Sep 2025 Issue date: 27 Oct 2020 |
Grant | Utility: Methods for treating neurological disorders using a synergistic small molecule and nucleic acids therapeutic approach Filling date: 26 Sep 2025 Issue date: 20 Oct 2020 |
Grant | Utility: Reduced size self-delivering RNAI compounds Filling date: 26 Sep 2025 Issue date: 15 Sep 2020 |
Grant | Utility: RNA interference in ocular indications Filling date: 26 Sep 2025 Issue date: 26 May 2020 |
Grant | Utility: Modified RNAi polynucleotides and uses thereof Filling date: 26 Sep 2025 Issue date: 28 Apr 2020 |
Grant | Utility: RNA duplexes with single stranded phosphorothioate nucleotide regions for additional functionality Filling date: 26 Sep 2025 Issue date: 19 Nov 2019 |
Showing 1 to 14 of 14 patents.